Multiple System Atrophy Treatment Status and Improvements after Treatment
Till the end of 2014, our department has treated 68 patients of multiple system atrophy, with 49 male patients and 19 female patients, including 10 hereditary cases, and the age of patients is between 28-66 years old. The treatment effect is closely related to the type of disease, treating time of the disease and patient’s specific disease progress. When treating, the treating effect of early to mid stage patient (before the disease damages language and deglutition function) is better than that of patients in the later stage; patient who progress slower will achieve better treatment effect......Read More >>
Multiple System Atrophy Cases
Name: Mr. Bai
Diagnosis: Olivopontocerebellar atrophy(OPCA)
Condition of Mr. Bai, a Hereditary OPCA patient. 1. Patient could not walk steady, with more and more faster pace and his heel could not get off the ground. He fell easily when he walk, especially when he walk straight,the more he try, the more deviated.....
Send Us Questions
Multiple System Atrophy
Multiple System Atrophy (MSA) is a degenerative neurological disorder. It is related to the degeneration of nerve cells in certain areas of the brain, which causes disorders with movement, balance, and other autonomic functions of the body such as bladder control or blood-pressure regulation. No certain risk factors or cause of MSA has been identified yet. Men in the late 50s to early 60s are more likely to suffer the disease.
Multiple System Atrophy Symptoms
Multiple System Atrophy is characterized by a combination of parkinsonism, autonomic dysfunction, and ataxia (Poor coordination / unsteady walking). As the disease progresses three groups of symptoms predominate, the symptoms would be:......
Read More Symptoms of Multiple System Atrophy >>
The Stem Cell Department of General Hospital of Chinese People’s Armed Police Forces and the 309th Hospital of Chinese People's Liberation Army is the first neural stem cell transplantation center at home and abroad, which went through WHO clinical trial registration, obtained the FDA clinical trial approval and had laboratory with GMP certification of stem cell research and preparation. Leaders in stem cell treatments for cerebral palsy, spinal cord injury, traumatic brain injury syndrome, ulcerative colitis, cirrhosis, stroke, diabetes and multiple system atrophy. Till now, we have used stem cell therapy to treat about 10,000+ patients from more than 30 countries. More About Us >>